应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09995 荣昌生物
已收盘 04-26 16:08:20
30.500
+0.250
+0.83%
最高
31.050
最低
29.650
成交量
116.92万
今开
29.650
昨收
30.250
日振幅
4.63%
总市值
166.00亿
流通市值
57.82亿
总股本
5.44亿
成交额
3,576万
换手率
0.62%
流通股本
1.90亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
荣昌生物(09995)公布一季度业绩 归母净亏损约3.49亿元 同比扩大约7.77%
智通财经网 · 56分钟前
荣昌生物(09995)公布一季度业绩 归母净亏损约3.49亿元 同比扩大约7.77%
荣昌生物(688331.SH)发布一季度业绩 净亏损3.49亿元
智通财经 · 20:05
荣昌生物(688331.SH)发布一季度业绩 净亏损3.49亿元
ADC赛道投资分水岭显现,“错锋竞争+造血研发”成新风向标?
智通财经 · 16:18
ADC赛道投资分水岭显现,“错锋竞争+造血研发”成新风向标?
港股异动 | 创新药概念股走高 科济药业-B(02171)涨超11% 创新药迎来全流程支持机制
智通财经 · 04-25 11:17
港股异动 | 创新药概念股走高 科济药业-B(02171)涨超11% 创新药迎来全流程支持机制
科济药业、荣昌生物大涨!恒生医药ETF再度涨超2%
每日经济新闻 · 04-25 11:13
科济药业、荣昌生物大涨!恒生医药ETF再度涨超2%
“抗癌先锋”亏掉29亿再融25亿,荣昌生物烧出一个未来?
新浪财经 · 04-24 18:53
“抗癌先锋”亏掉29亿再融25亿,荣昌生物烧出一个未来?
4月23日荣昌生物涨8.46%,易方达医疗保健行业混合A基金重仓该股
证券之星 · 04-23
4月23日荣昌生物涨8.46%,易方达医疗保健行业混合A基金重仓该股
生物医药板块午后发力 药明合联(02268)涨8.59% 机构指行业今年依然有结构性增量
金吾财讯 · 04-23
生物医药板块午后发力 药明合联(02268)涨8.59% 机构指行业今年依然有结构性增量
生物科技概念盘中拉升,荣昌生物涨7.90%
自选股智能写手 · 04-23
生物科技概念盘中拉升,荣昌生物涨7.90%
荣昌生物盘中异动 下午盘股价大涨5.11%
自选股智能写手 · 04-23
荣昌生物盘中异动 下午盘股价大涨5.11%
港股异动 | 荣昌生物(09995)再涨超4% 公司拟定增近26亿元 机构称今年催化剂众多
智通财经 · 04-23
港股异动 | 荣昌生物(09995)再涨超4% 公司拟定增近26亿元 机构称今年催化剂众多
北向资金4月19日净买入荣昌生物2.65万股 连续5日增持
自选股智能写手 · 04-22
北向资金4月19日净买入荣昌生物2.65万股 连续5日增持
北向资金4月17日净买入荣昌生物2.49万股 连续3日增持
自选股智能写手 · 04-18
北向资金4月17日净买入荣昌生物2.49万股 连续3日增持
鲁泰A:公司目前持有荣昌生物约391万股,暂无减持计划
证券之星 · 04-17
鲁泰A:公司目前持有荣昌生物约391万股,暂无减持计划
鲁泰A(000726.SZ):目前持有荣昌生物约391万股,暂无减持计划
格隆汇资讯 · 04-17
鲁泰A(000726.SZ):目前持有荣昌生物约391万股,暂无减持计划
连亏两年、又抛25.5亿元定增,荣昌生物钱花哪了
蓝鲸财经 · 04-17
连亏两年、又抛25.5亿元定增,荣昌生物钱花哪了
荣昌生物获得实用新型专利授权:“一种以光圈方式开合的传递孔组件和传递窗”
证券之星 · 04-17
荣昌生物获得实用新型专利授权:“一种以光圈方式开合的传递孔组件和传递窗”
荣昌生物(09995.HK)拟4月26日举行董事会会议批准一季度业绩
格隆汇资讯 · 04-16
荣昌生物(09995.HK)拟4月26日举行董事会会议批准一季度业绩
荣昌生物盘中异动 大幅跳水5.14%报27.700港元
自选股智能写手 · 04-16
荣昌生物盘中异动 大幅跳水5.14%报27.700港元
荣昌生物(09995)股价下跌5.308%,现价港币$27.65
阿斯达克财经 · 04-16
荣昌生物(09995)股价下跌5.308%,现价港币$27.65
加载更多
公司概况
公司名称:
荣昌生物
所属市场:
SEHK
上市日期:
--
主营业务:
荣昌生物制药(烟台)股份有限公司是一家主要从事创新型生物药研发和制造的中国公司。该公司专注于抗体药物偶联物(ADC)、抗体融合蛋白、单克隆抗体及双特异性抗体等治疗性抗体药物的发现、开发与商业化。该公司的主要产品包括泰它西普(RC18)、维迪西妥单抗(RC48)和双靶点融合蛋白(RC28)。该公司的产品主要应用于治疗自身免疫疾病、肿瘤和眼科等重大疾病。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":30.5,"timestamp":1714118900021,"preClose":30.25,"halted":0,"volume":1169158,"delay":0,"floatShares":189581239,"shares":544263003,"eps":-3.0176222,"marketStatus":"已收盘","marketStatusCode":5,"change":0.25,"latestTime":"04-26 16:08:20","open":29.65,"high":31.05,"low":29.65,"amount":35757266,"amplitude":0.046281,"askPrice":30.5,"askSize":5500,"bidPrice":30.25,"bidSize":6500,"shortable":3,"etf":0,"ttmEps":-3.0176221455020866,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714354200000},"adr":0,"listingDate":1604851200000,"adjPreClose":30.25,"openAndCloseTimeList":[[1714095000000,1714104000000],[1714107600000,1714118400000]],"volumeRatio":0.94907,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":56.46,"timestamp":1714114800000,"preClose":55.29,"halted":0,"volume":1545796,"delay":0,"premium":"-49.88"}},"requestUrl":"/m/hq/s/09995","defaultTab":"news","newsList":[{"id":"2430927952","title":"荣昌生物(09995)公布一季度业绩 归母净亏损约3.49亿元 同比扩大约7.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430927952","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2430927952?lang=zh_cn&edition=full","pubTime":"2024-04-26 20:37","pubTimestamp":1714135035,"startTime":"0","endTime":"0","summary":"荣昌生物(09995)公布2024年第一季度业绩,营业收入约3.3亿元,同比增长9...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_27.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_27.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1112269.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430275375","title":"荣昌生物(688331.SH)发布一季度业绩 净亏损3.49亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430275375","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430275375?lang=zh_cn&edition=full","pubTime":"2024-04-26 20:05","pubTimestamp":1714133107,"startTime":"0","endTime":"0","summary":"智通财经APP讯,荣昌生物(688331.SH)披露2024年第一季度报告,该公司报告期实现营业收入3.30亿元,同比增长96.41%。归属于上市公司股东的净亏损3.49亿元,归属于上市公司股东的扣除非经常性损益的净亏损3.46亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1112190.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430241913","title":"ADC赛道投资分水岭显现,“错锋竞争+造血研发”成新风向标?","url":"https://stock-news.laohu8.com/highlight/detail?id=2430241913","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430241913?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:18","pubTimestamp":1714119495,"startTime":"0","endTime":"0","summary":"今年4月3日,丹麦药企Genmab宣布将以18亿美元全现金交易形式收购一家中国本土的ADC药物研发Biotech普方生物,从而获得其自主研发的ADC技术资产。此前国金证券公布的一份研报也显示,国内ADC在研药物有超过60个是靶向HER2,位居首位。但在强调差异化的ADC赛道,聚集成熟靶点并非一件好事,随着市场竞争趋于白热化,研发企业能否从有限的适应症市场分得一杯羹成为一个未知数,也影响市场对公司后续价值的判断。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111461.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430443247","title":"港股异动 | 创新药概念股走高 科济药业-B(02171)涨超11% 创新药迎来全流程支持机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2430443247","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430443247?lang=zh_cn&edition=full","pubTime":"2024-04-25 11:17","pubTimestamp":1714015021,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,创新药概念股持续走高,截至发稿,科济药业-B(02171)涨10.3%,报5.57港元;来凯医药-B(02105)涨9.15%,报6.44港元;荣昌生物(09995)涨6.29%,报31.25港元;君实生物(01877)涨5.65%,报10.28港元。甬兴证券指出,2023年医保基金运行总体平稳,该行认为随着国家医保局建立覆盖申报、评审、测算、谈判等全流程的创新药支持机制,更多新药好药有望纳入医保,创新药研发相关企业有望受益。东海证券表示,今年以来包括对创新药的明确支持、集采续约条款的持续优化等,行业政策向好态势明显;二季度以后板块整体有望持续转暖向好。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109550.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430443437","title":"科济药业、荣昌生物大涨!恒生医药ETF再度涨超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430443437","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430443437?lang=zh_cn&edition=full","pubTime":"2024-04-25 11:13","pubTimestamp":1714014780,"startTime":"0","endTime":"0","summary":"随着港股市场持续回暖,相关ETF本周交投火热,恒生互联网ETF(513330)、恒生科技指数ETF(513180)近日霸榜跨境型ETF成交额榜一、榜二。港股医药板块今日强势领涨,科济药业、荣昌生物、百济神州、乐普生物等强势领涨。恒生医药ETF(159892)则在上周五触及历史底部后已连续4个交易日涨幅突破2%,今日盘中涨幅一度上榜全市场前三!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251115307a557685&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251115307a557685&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429439240","title":"“抗癌先锋”亏掉29亿再融25亿,荣昌生物烧出一个未来?","url":"https://stock-news.laohu8.com/highlight/detail?id=2429439240","media":"新浪财经","top":-1,"share":"https://www.laohu8.com/m/news/2429439240?lang=zh_cn&edition=full","pubTime":"2024-04-24 18:53","pubTimestamp":1713955980,"startTime":"0","endTime":"0","summary":"早在3月底,荣昌生物就发布了一笔总额25.5亿元的定增预案,但在预案发出时,荣昌生物尚无确定的发行对象。 3年“烧掉”近15亿, 平安证券报告显示,上述两款产品在2023年的销售额均超过5亿元,成功把荣昌生物带入创新药企第二梯队。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-04-24/doc-inasxuyu8395932.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-04-24/doc-inasxuyu8395932.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429150752","title":"4月23日荣昌生物涨8.46%,易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429150752","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429150752?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:26","pubTimestamp":1713860808,"startTime":"0","endTime":"0","summary":"证券之星消息,4月23日荣昌生物涨8.46%,收盘报53.83元,换手率1.27%,成交量2.06万手,成交额1.07亿元。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共34家,其中持有数量最多的公募基金为易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为57.24亿元,最新净值3.024,较上一交易日上涨1.92%,近一年下跌11.14%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300029748.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429027158","title":"生物医药板块午后发力 药明合联(02268)涨8.59% 机构指行业今年依然有结构性增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2429027158","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2429027158?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:53","pubTimestamp":1713851628,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块午后发力走高,药明合联 涨8.59%,荣昌生物涨6.53%,信达生物涨6.48%,康希诺生物涨6.4%,维亚生物涨5.88%,和黄医药涨5.58%,康方生物涨5.41%。华鑫证券表示,2024年1季度行业增长受到同期基数影响较为明显,如零售药店、POCT等,展望2024年全年,1季度高增长方向具有代表性,其增长趋势有望延续,医药行业依然有结构性增量。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/OTA2NWNmYzE4MTQyOTUwMjEyNTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OTA2NWNmYzE4MTQyOTUwMjEyNTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1935593","is_publish_highlight":false,"gpt_icon":0},{"id":"2429130000","title":"生物科技概念盘中拉升,荣昌生物涨7.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429130000","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429130000?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:35","pubTimestamp":1713850521,"startTime":"0","endTime":"0","summary":"04月23日,生物科技概念盘中拉升,截至13点35分,生物科技概念整体指数上涨0.50%,报778.560点。从个股上来看,该概念的成分股中,荣昌生物涨7.90%,泰林生物、苏豪弘业、华康医疗涨幅居前。从资金上来看,截止发稿,生物科技概念主力净流入为-1.79亿,其中达安基因受到资金热捧,主力净流入662.00万;拉长时间线来看,该板块近20日主力资金净流入-13.74亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042313352187e82c13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042313352187e82c13&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429335130","title":"荣昌生物盘中异动 下午盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429335130","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429335130?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:19","pubTimestamp":1713849574,"startTime":"0","endTime":"0","summary":"2024年04月23日下午盘13时19分,荣昌生物股票出现波动,股价急速上涨5.11%。截至发稿,该股报29.800港元/股,成交量69.1万股,换手率0.36%,振幅5.47%。机构评级方面,在所有19家参与评级的机构中,89%的券商给予买入建议,11%的券商给予持有建议,无券商给予卖出建议。荣昌生物股票所在的生物技术行业中,整体涨幅为0.82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042313193479228227&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042313193479228227&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429135217","title":"港股异动 | 荣昌生物(09995)再涨超4% 公司拟定增近26亿元 机构称今年催化剂众多","url":"https://stock-news.laohu8.com/highlight/detail?id=2429135217","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429135217?lang=zh_cn&edition=full","pubTime":"2024-04-23 11:04","pubTimestamp":1713841499,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,荣昌生物再涨超4%,截至发稿,涨4.76%,报29.7港元,成交额1267.92万港元。消息面上,3月底,荣昌生物宣布定增预案,计划最高募资25.5亿元,全部用于“新药研发项目”。公司同时发布2023年业绩;公司营业收入同比增长10.83亿元,同比增加40.26%;净亏损为15.11亿元,同比增加5.12亿元。同时随着公司拟向特定对象募资不超过25.5亿元,公司的整体财务结构有望得到优化,同时在研新药的研发有望得到推动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107348.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429690529","title":"北向资金4月19日净买入荣昌生物2.65万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2429690529","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429690529?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:30","pubTimestamp":1713749434,"startTime":"0","endTime":"0","summary":"4月19日, 北向资金增持荣昌生物2.65万股,连续5日增持。截止当日收盘,沪股通共持有荣昌生物144.41万股,占流通股0.89%。沪股通增持金额前五个股分别为万华化学、中信证券、珀莱雅、华阳股份、平煤股份。荣昌生物近5个交易日下跌10.78%,沪股通累计增持25.68万股;近20个交易日下跌14.48%,沪股通累计增持39.33万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422093525879ecc28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422093525879ecc28&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428588396","title":"北向资金4月17日净买入荣昌生物2.49万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2428588396","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428588396?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:30","pubTimestamp":1713403831,"startTime":"0","endTime":"0","summary":"4月17日, 北向资金增持荣昌生物2.49万股,连续3日增持。截止当日收盘,沪股通共持有荣昌生物141.27万股,占流通股0.87%。沪股通增持金额前五个股分别为国电电力、大秦铁路、同仁堂、中国平安、赤峰黄金。荣昌生物近5个交易日下跌7.40%,沪股通累计增持5.86万股;近20个交易日下跌16.05%,沪股通累计增持39.69万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404180935318b3248df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404180935318b3248df&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428165603","title":"鲁泰A:公司目前持有荣昌生物约391万股,暂无减持计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2428165603","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428165603?lang=zh_cn&edition=full","pubTime":"2024-04-17 19:01","pubTimestamp":1713351701,"startTime":"0","endTime":"0","summary":"证券之星消息,鲁 泰A04月17日在投资者关系平台上答复投资者关心的问题。投资者:荣昌生物上市时鲁泰直接持有4218265股,减持部分股份后持有多少股份,后续继续减持吗?间接持有优必选,优必选港股价格180多元,权益价值是多少?公司目前持有荣昌生物约391万股,暂无减持计划。公司与灏浚投资共同设立的基金投资优比选约5000万元。公司服装面料当中未有抗辐射面料,感谢您的关注。鲁 泰A董秘:尊敬的投资者您好!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041700039533.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428397861","title":"鲁泰A(000726.SZ):目前持有荣昌生物约391万股,暂无减持计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2428397861","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2428397861?lang=zh_cn&edition=full","pubTime":"2024-04-17 17:39","pubTimestamp":1713346794,"startTime":"0","endTime":"0","summary":"格隆汇4月17日丨鲁泰A(000726.SZ)在投资者互动平台表示,公司目前持有荣昌生物约391万股,暂无减持计划。公司与灏浚投资共同设立的基金投资优比选约5000万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417174005878852e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417174005878852e7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428356102","title":"连亏两年、又抛25.5亿元定增,荣昌生物钱花哪了","url":"https://stock-news.laohu8.com/highlight/detail?id=2428356102","media":"蓝鲸财经","top":-1,"share":"https://www.laohu8.com/m/news/2428356102?lang=zh_cn&edition=full","pubTime":"2024-04-17 11:33","pubTimestamp":1713324815,"startTime":"0","endTime":"0","summary":"“上市才两年,钱就花完了?”针对3月30日荣昌生物的拟定增不超25.5亿元公告,有投资者如是说。实际上,荣昌生物的缺钱争议早就有之。2022年2月,荣昌生物如愿登陆科创板,募资净额25.06亿元,成为山东首家“A+H”上市的医药生物企业。2023年,泰它西普产量85.94万支,销量同比增长59.37%至78.23万支,产销率91.02%。维迪西妥单抗产量26.56万支,销量同比增长15.24%至17","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/230610","is_publish_highlight":false,"gpt_icon":0},{"id":"2428801373","title":"荣昌生物获得实用新型专利授权:“一种以光圈方式开合的传递孔组件和传递窗”","url":"https://stock-news.laohu8.com/highlight/detail?id=2428801373","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428801373?lang=zh_cn&edition=full","pubTime":"2024-04-17 02:41","pubTimestamp":1713292917,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示荣昌生物新获得一项实用新型专利授权,专利名为“一种以光圈方式开合的传递孔组件和传递窗”,专利申请号为CN202322384767.6,授权日为2024年4月16日。今年以来荣昌生物新获得专利授权2个,较去年同期增加了100%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041700003703.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2427810280","title":"荣昌生物(09995.HK)拟4月26日举行董事会会议批准一季度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2427810280","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2427810280?lang=zh_cn&edition=full","pubTime":"2024-04-16 16:32","pubTimestamp":1713256339,"startTime":"0","endTime":"0","summary":"格隆汇4月16日丨荣昌生物(09995.HK)发布公告,公司将于2024年4月26日(星期五)举行董事会会议,藉以(其中包括)考虑及批准公司及其附属公司截至2024年3月31日止三个月的未经审计第一季度业绩及其刊发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161632258b299ff5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161632258b299ff5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427454865","title":"荣昌生物盘中异动 大幅跳水5.14%报27.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427454865","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427454865?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:50","pubTimestamp":1713232212,"startTime":"0","endTime":"0","summary":"2024年04月16日早盘09时50分,荣昌生物股票出现波动,股价急速下挫5.14%。截至发稿,该股报27.700港元/股,成交量43.8万股,换手率0.23%,振幅4.11%。资金方面,该股资金流入345.012万港元,流出646.765万港元。荣昌生物股票所在的生物技术行业中,整体跌幅为0.30%。其相关个股中,奥星生命科技、正大企业国际、和铂医药-B涨幅较大,振幅较大的相关个股有来凯医药-B、圣诺医药-B、科济药业-B,振幅分别为14.21%、11.10%、7.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041609501387e80a42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041609501387e80a42&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427636758","title":"荣昌生物(09995)股价下跌5.308%,现价港币$27.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2427636758","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427636758?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:45","pubTimestamp":1713231900,"startTime":"0","endTime":"0","summary":"[下跌股]荣昌生物(09995) 股价在上午09:45比前收市价下跌5.308%,现股价为港币$27.65。至目前为止,今日最高价为$28.7,而最低价为$27.65。总成交量为28.95万股,总成交金额为港币$816.985万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240416823/aamm-all-category","is_publish_highlight":false,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1081},{"period":"1month","weight":0.1635},{"period":"3month","weight":0.5641},{"period":"6month","weight":-0.2693},{"period":"1year","weight":-0.3529},{"period":"ytd","weight":-0.1923}],"compareEarnings":[{"period":"1week","weight":0.0548},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0835},{"period":"6month","weight":-0.0066},{"period":"1year","weight":-0.1252},{"period":"ytd","weight":0.0139}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"荣昌生物制药(烟台)股份有限公司是一家主要从事创新型生物药研发和制造的中国公司。该公司专注于抗体药物偶联物(ADC)、抗体融合蛋白、单克隆抗体及双特异性抗体等治疗性抗体药物的发现、开发与商业化。该公司的主要产品包括泰它西普(RC18)、维迪西妥单抗(RC48)和双靶点融合蛋白(RC28)。该公司的产品主要应用于治疗自身免疫疾病、肿瘤和眼科等重大疾病。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.188174},{"month":2,"riseRate":0.75,"avgChangeRate":0.173193},{"month":3,"riseRate":0.25,"avgChangeRate":-0.108046},{"month":4,"riseRate":0.75,"avgChangeRate":0.000183},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.0969},{"month":6,"riseRate":1,"avgChangeRate":0.180883},{"month":7,"riseRate":0.666667,"avgChangeRate":0.049642},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.052805},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.023458},{"month":10,"riseRate":0.666667,"avgChangeRate":0.128837},{"month":11,"riseRate":1,"avgChangeRate":0.035442},{"month":12,"riseRate":0.5,"avgChangeRate":0.023444}],"exchange":"SEHK","name":"荣昌生物","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,09995,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}